Anna Sureda Balari

68PUBLICATIONS

428CO-AUTHORS

Predictive and prognostic markersTransplantation immunologyHaematologyGene and molecular therapyQuery processing and optimisation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (68)

Sort by Publication Date:

|Jun 19, 2026

The impact of IPI risk factors on CAR T-cell therapy or allogeneic stem cell transplantation for treatment of relapsed or refractory large B-cell lymphoma (LBCL).

|Jun 15, 2026

Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party study.

|Jun 03, 2026

Defining lines of therapy in haematological malignancies: a proposed systematic and comprehensive framework from the EBMT Practice Harmonisation and Guidelines Committee.

|May 27, 2026

The 2024 EBMT activity report: crossing one million HCTs and 20,000 CAR-T. A landmark in cellular therapy.

|Mar 11, 2026

An extraction pipeline for analysis of hematopoietic stem cell transplantation data.

Erik G J von Asmuth, Constantijn J M Halkes, Jurjen Versluis

|Mar 04, 2026

Outcomes of patients over 70 years treated with brexu-cel for R/R mantle cell lymphoma: a study from the CTIWP of EBMT.

Nicole Santoro, Jarl Eduard Mooyaart, Urban Novak

Pageof 12

Frequent Collaborators

13 joint publications

Ali Bazarbachi

10 joint publications

Donal P McLornan

Raffaella Greco

Annalisa Ruggeri

Alberto Mussetti

Nicolaus Kröger

Fabio Ciceri

Isabel Sánchez-Ortega

7 joint publications

Mehdi Hamadani

7 joint publications

Albert Ortiol

Frequent Collaborators

13 joint publications

Ali Bazarbachi

10 joint publications

Donal P McLornan

9 joint publications

Raffaella Greco

9 joint publications

Annalisa Ruggeri